Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus
Year: 2016
Type: review
Source: European Heart Journal
Authors: Nikolaus Marx, Darren K. McGuire
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, empagliflozin, type 2 diabetes, cardiovascular events, cardiovascular risk reduction, EMPA-REG OUTCOME trial, heart failure hospitalization, cardiovascular mortality, myocardial infarction, stroke, hyperglycemia, atherosclerotic cardiovascular disease, renal hemodynamics, sodium depletion, blood pressure reduction, weight loss
Open Access status: closed
OpenAlex ID: W2346113118
